About: covid:PMC7203794

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: covid:PMC7203794 Goto Sponge NotDistinct Permalink

An Entity of Type : owl:Thing, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
Creator	Zhang, Xia Jiang, Xin Li, Cui Zhang, Tong Zhang, Zhi-Jie Chu, Nai-Hui Deng, Qun-Yi Fu, Ji-You Guo, Xiao-Yan Lu, Zhen-Hui Qiu, Lei Shao, Chang-Rong Wang, Zhao-Long Wu, Ding-Zhong Xiao, He-Ping Yan, Xiao-Feng Zhang, Hui-Yong Zhang, Shao-Yan Zheng, Pei-Yong Zheng, Yue-Juan
is schema:about of	named entity 'adjuvant therapy' named entity 'pulmonary tuberculosis' named entity 'traditional Chinese medicine' named entity 'adjuvant therapy' named entity 'lesion' named entity 'decoction' named entity 'adverse events' named entity 'herbal medicine' named entity 'treatment group' named entity 'pyrazinamide' named entity 'WHO' named entity 'isoniazid' named entity 'adjunct therapy' named entity 'immunocompromised' named entity 'TCM' named entity 'China' named entity 'Stemona' named entity 'adjuvant therapy' named entity 'traditional Chinese medicine' named entity 'treatment regimens' named entity 'informed consent' named entity 'placebo group' named entity 'TCM' named entity 'TCM' named entity 'pyrazinamide' named entity 'host immunity' named entity 'ethambutol' named entity 'lesion' named entity 'culture conversion' named entity 'bloating' named entity 'Hebei' named entity 'adjuvant treatment' named entity 'sputum culture' named entity 'Shanghai' named entity 'case report form' named entity 'primary outcome measure' named entity 'TB drug' named entity 'Delphi method' named entity 'baicalin' named entity 'phase III clinical trials' named entity 'lesion' named entity 'long-term' named entity 'sputum' named entity 'Shenzhen' named entity 'bacteriostatic' named entity 'meta-analysis' named entity 'culture conversion' named entity '25.0' named entity 'sputum culture' named entity 'Pharmacological' named entity 'subgroup analysis' named entity 'pruritus' named entity 'radiologists' named entity 'streptomycin' named entity 'TCM' named entity 'sputum' named entity 'double-blind method' named entity 'micro-organisms' named entity 'adverse reactions' named entity 'Mycobacterium tuberculosis' named entity 'streptomycin' named entity 'mental illness' named entity 'decoction' named entity 'N-acetyl-L-cysteine' named entity 'pyrazinamide' named entity 'drug resistance' named entity 'case report form' named entity 'sputum' named entity 'active ingredients' named entity 'sputum' named entity 'cough' named entity 'block size' named entity 'susceptibility testing' named entity 'adverse reaction' named entity 'significant difference' named entity 'China' named entity 'urine' named entity 'TB treatment' named entity 'relapse' named entity 'ethanol'

Attributes

Values

Creator

Zhang, Xia
Jiang, Xin
Li, Cui
Zhang, Tong
Zhang, Zhi-Jie
Chu, Nai-Hui
Deng, Qun-Yi
Fu, Ji-You
Guo, Xiao-Yan
Lu, Zhen-Hui
Qiu, Lei
Shao, Chang-Rong
Wang, Zhao-Long
Wu, Ding-Zhong
Xiao, He-Ping
Yan, Xiao-Feng
Zhang, Hui-Yong
Zhang, Shao-Yan
Zheng, Pei-Yong
Zheng, Yue-Juan

is schema:about of

named entity 'adjuvant therapy'
named entity 'pulmonary tuberculosis'
named entity 'traditional Chinese medicine'
named entity 'adjuvant therapy'
named entity 'lesion'
named entity 'decoction'
named entity 'adverse events'
named entity 'herbal medicine'
named entity 'treatment group'
named entity 'pyrazinamide'
named entity 'WHO'
named entity 'isoniazid'
named entity 'adjunct therapy'
named entity 'immunocompromised'
named entity 'TCM'
named entity 'China'
named entity 'Stemona'
named entity 'adjuvant therapy'
named entity 'traditional Chinese medicine'
named entity 'treatment regimens'
named entity 'informed consent'
named entity 'placebo group'
named entity 'TCM'
named entity 'TCM'
named entity 'pyrazinamide'
named entity 'host immunity'
named entity 'ethambutol'
named entity 'lesion'
named entity 'culture conversion'
named entity 'bloating'
named entity 'Hebei'
named entity 'adjuvant treatment'
named entity 'sputum culture'
named entity 'Shanghai'
named entity 'case report form'
named entity 'primary outcome measure'
named entity 'TB drug'
named entity 'Delphi method'
named entity 'baicalin'
named entity 'phase III clinical trials'
named entity 'lesion'
named entity 'long-term'
named entity 'sputum'
named entity 'Shenzhen'
named entity 'bacteriostatic'
named entity 'meta-analysis'
named entity 'culture conversion'
named entity '25.0'
named entity 'sputum culture'
named entity 'Pharmacological'
named entity 'subgroup analysis'
named entity 'pruritus'
named entity 'radiologists'
named entity 'streptomycin'
named entity 'TCM'
named entity 'sputum'
named entity 'double-blind method'
named entity 'micro-organisms'
named entity 'adverse reactions'
named entity 'Mycobacterium tuberculosis'
named entity 'streptomycin'
named entity 'mental illness'
named entity 'decoction'
named entity 'N-acetyl-L-cysteine'
named entity 'pyrazinamide'
named entity 'drug resistance'
named entity 'case report form'
named entity 'sputum'
named entity 'active ingredients'
named entity 'sputum'
named entity 'cough'
named entity 'block size'
named entity 'susceptibility testing'
named entity 'adverse reaction'
named entity 'significant difference'
named entity 'China'
named entity 'urine'
named entity 'TB treatment'
named entity 'relapse'
named entity 'ethanol'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software